- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Mediators of Inflammation
Volume 2013 (2013), Article ID 612848, 7 pages
Long-Term Leukocyte Filtration Should Be Avoided during Extracorporeal Circulation
1Department of Anesthesiology and Translational Neuroscience Center, West China Hospital, Sichuan University, 37 Wainan Guoxuexiang, Chengdu, Sichuan 610041, China
2Department of Thoracic Cardiovascular Surgery, Affiliated No. 2 Hospital, Zhejiang University, No. 88 Jiefang Road, Hangzhou, Zhejiang 310009, China
3Department of Laboratory Medicine, West China Hospital, Sichuan University, 37 Wainan Guoxuexiang, Chengdu, Sichuan 610041, China
Received 5 November 2013; Revised 18 December 2013; Accepted 19 December 2013
Academic Editor: Helen C. Steel
Copyright © 2013 Jiali Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. Tönz, T. Mihaljevic, L. K. Von Segesser, J. Fehr, E. R. Schmid, and M. I. Turina, “Acute lung injury during cardiopulmonary bypass are the neutrophils responsible?” Chest, vol. 108, no. 6, pp. 1551–1556, 1995.
- D. Cameron, “Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors,” Journal of Cardiovascular Pharmacology, vol. 27, no. 1, supplement, pp. S1–S5, 1996.
- J. Zhou, X.-D. Wu, K. Lin et al., “Blood hibernation: a novel strategy to inhibit systemic inflammation and coagulation induced by cardiopulmonary bypass,” Chinese Medical Journal, vol. 123, no. 13, pp. 1741–1747, 2010.
- L. Du, J. Zhou, J. Zhang, et al., “Actin filament re-organization is a key step in lung inflammation induced by systemic inflammatory response syndrome,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, pp. 597–603, 2012.
- L. Du, J. Zhou, J. Tang et al., “Aprotinin combined with nitric oxide and prostaglandin E1 protects the canine kidney from cardiopulmonary bypass-induced injury,” European Journal of Cardio-Thoracic Surgery, vol. 38, no. 1, pp. 98–103, 2010.
- S. T. Baksaas, H. I. Flom-Halvorsen, E. Øvrum et al., “Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery,” Perfusion, vol. 14, no. 2, pp. 107–117, 1999.
- Y. J. Gu, A. J. De Vries, P. W. Boonstra, and W. Van Oeveren, “Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 112, no. 2, pp. 494–500, 1996.
- C. G. de Amorim, L. M. Malbouisson, F. C. da Silva Jr., et al., “Leukocyte depletion during CPB: effects on inflammation and lung function,” Inflammation. In press.
- S. Gunaydin, T. Modine, T. Sari, Y. Zorlutuna, and T. Gourlay, “Clinical efficacy of two-phase leukocyte filtration in high-risk patients undergoing coronary revascularization with cardiopulmonary bypass,” Journal of Extra-Corporeal Technology, vol. 41, no. 3, pp. 149–156, 2009.
- A. S. Rubino, G. F. Serraino, R. Marsico, et al., “Leukocyte filtration improves pulmonary function and reduces the need for postoperative non-invasive ventilation,” International Journal of Artificial Organs, vol. 35, pp. 679–688, 2012.
- S. T. Baksaas, V. Videm, T. E. Mollnes et al., “Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets,” Perfusion, vol. 13, no. 6, pp. 429–436, 1998.
- A. G. Loberg, J. Stallard, J. Dunning, and J. Dark, “Can leucocyte depletion reduce reperfusion injury following cardiopulmonary bypass?” Interactive Cardiovascular and Thoracic Surgery, vol. 12, no. 2, pp. 232–237, 2011.
- A. S. Rubino, G. F. Serraino, G. Mariscalco, R. Marsico, A. Sala, and A. Renzulli, “Leukocyte depletion during extracorporeal circulation allows better organ protection but does not change hospital outcomes,” Annals of Thoracic Surgery, vol. 91, no. 2, pp. 534–540, 2011.
- M. Scholz, A. Simon, G. Matheis et al., “Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery,” Inflammation Research, vol. 51, no. 7, pp. 363–368, 2002.
- M. Ilmakunnas, E. J. Pesonen, J. Ahonen, J. Rämö, S. Siitonen, and H. Repo, “Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 129, no. 4, pp. 851–859, 2005.
- V. A. Ferraris, J. R. Brown, G. J. Despotis et al., “2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines,” Annals of Thoracic Surgery, vol. 91, no. 3, pp. 944–982, 2011.
- S. Schneider, H. Gunasinghe, J. Sistino, M. Blackwell, and F. Spinale, “Effects of leukocyte depletion filters on matrix metalloproteinase activation in an extracorporeal circulation circuit,” Journal of Extra-Corporeal Technology, vol. 35, no. 2, pp. 139–142, 2003.
- K. Tao, Q. An, K. Lin et al., “Which is better to preserve pulmonary function: short-term or prolonged leukocyte depletion during cardiopulmonary bypass?” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 6, pp. 1385–1391, 2009.
- L. Du, L. Gong, L. Li, et al., “The feasibility of karyocyte scavenger for intraoperative blood salvage during oncosurgery,” Chinese Journal of Blood Transfusion, vol. 24, pp. 644–649, 2011.
- G. P. Lewis, “Method using ortho-tolidine for the quantitative determination of haemoglobin in serum and urine,” Journal of Clinical Pathology, vol. 18, pp. 235–239, 1965.
- K. Crozat, C. Eidenschenk, B. N. Jaeger et al., “Impact of β2 integrin deficiency on mouse natural killer cell development and function,” Blood, vol. 117, no. 10, pp. 2874–2882, 2011.
- K. Morioka, R. Muraoka, Y. Chiba et al., “Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 111, no. 1, pp. 45–54, 1996.
- Y. Chiba, K. Morioka, R. Muraoka et al., “Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 65, no. 1, pp. 107–114, 1998.
- D. F. Treacher, M. Sabbato, K. A. Brown, and V. Gant, “The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass,” Perfusion, vol. 16, supplement, pp. 67–73, 2001.
- T. E. Karaiskos, G. M. Palatianos, C. D. Triantafillou et al., “Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease,” Annals of Thoracic Surgery, vol. 78, no. 4, pp. 1339–1344, 2004.
- A. H. Olivencia-Yurvati, N. Wallace, S. Ford, and R. T. Mallet, “Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection,” Perfusion, vol. 19, no. 1, pp. S13–S19, 2004.